These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7681650)

  • 21. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.
    Tseng TC; Liu CJ; Su TH; Wang CC; Chen CL; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2011 Aug; 141(2):517-25, 525.e1-2. PubMed ID: 21672542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
    de Niet A; Jansen L; Zaaijer HL; Klause U; Takkenberg B; Janssen HL; Chu T; Petric R; Reesink HW
    Antivir Ther; 2014; 19(3):259-67. PubMed ID: 24256626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus associated membranous glomerulonephritis.
    Wiggelinkhuizen J; Sinclair-Smith C; Stannard LM; Smuts H
    Arch Dis Child; 1983 Jul; 58(7):488-96. PubMed ID: 6870328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B e antigen-associated membranous nephropathy.
    Lee HS; Koh HI
    Nephron; 1989; 52(4):356-9. PubMed ID: 2671764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
    Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients.
    Maylin S; Boyd A; Lavocat F; Gozlan J; Lascoux-Combe C; Miailhes P; Lassel L; Delaugerre C; Girard PM; Zoulim F; Lacombe K
    AIDS; 2012 May; 26(8):939-49. PubMed ID: 22333748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus.
    Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K
    AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus-associated membraneous nephropathy: clinical features, immunological profiles and outcome.
    Lin CY
    Nephron; 1990; 55(1):37-44. PubMed ID: 2191232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study.
    Ségéral O; N'Diaye DS; Prak S; Nouhin J; Chhun S; Khamduang W; Chim K; Roque-Afonso AM; Piola P; Borand L; Ngo-Giang-Huong N; Rouet F;
    J Clin Virol; 2018 Dec; 109():29-34. PubMed ID: 30388664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients.
    Ma H; Yang RF; Wei L
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1498-506. PubMed ID: 20796146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B.
    Peng CY; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen CH
    Sci Rep; 2017 Feb; 7():42879. PubMed ID: 28220833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients.
    Qiu YW; Huang LH; Yang WL; Wang Z; Zhang B; Li YG; Su TT; Zhou HY; Xu W; Wang XD; Dai YP; Gan JH
    Int J Infect Dis; 2016 Feb; 43():43-48. PubMed ID: 26523639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients.
    Chan HL; Wong GL; Chim AM; Chan HY; Chu SH; Wong VW
    Antivir Ther; 2011; 16(8):1249-57. PubMed ID: 22155906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection.
    Zeng DW; Liu YR; Dong J; Zhu YY; Li YB; Chen J; Zheng Q; Jiang JJ
    Mol Med Rep; 2015 May; 11(5):3465-72. PubMed ID: 25592612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women.
    Sun KX; Li J; Zhu FC; Liu JX; Li RC; Zhai XJ; Li YP; Chang ZJ; Nie JJ; Zhuang H
    Vaccine; 2012 Aug; 30(36):5335-40. PubMed ID: 22749833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection.
    Furusyo N; Hayashi J; Sawayama Y; Kishihara Y; Kashiwagi S
    Am J Trop Med Hyg; 1999 Apr; 60(4):616-22. PubMed ID: 10348237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy.
    Lin TC; Chiu YC; Chiu HC; Liu WC; Cheng PN; Chen CY; Chang TT; Wu IC
    World J Gastroenterol; 2018 Feb; 24(6):725-736. PubMed ID: 29456411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection.
    Chen CH; Hung CH; Hu TH; Wang JH; Lu SN; Su PF; Lee CM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1984-92.e1. PubMed ID: 26073492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.